Financials

  • Market Capitalization 3.72 B
  • Employee 1 184
  • Founded 2015
  • CEO Christian Behrenbruch
  • Website www.telixpharma.com
  • Headquarter Australia
  • FIGI BBG01N69K900
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Deuda total
Flujo de caja libre
Efectivo y equivalentes

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
1527
NAMS
NewAmsterdam Pharma Company N.V. - Ordinary Shares
33.28 USD-5.62%-5.00%+6.74%-8.24%3.89 B USD
1535
CPRX
Catalyst Pharmaceuticals, Inc. - Common Stock
31.48 USD+0.03%-0.03%+0.38%+48.42%3.85 B USD
1563
GPCR
Structure Therapeutics Inc - American Depositary Shares
51.64 USD-3.22%-8.71%+20.09%+93.12%3.67 B USD
1575
RLAY
Relay Therapeutics, Inc. - Common Stock
18.73 USD-6.40%-1.27%+24.53%+424.65%3.59 B USD